pre-leukemic stem cells: a telltale sign of aml
Published 6 years ago • 273 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:49
targeting leukemic stem cells in aml
-
2:27
session highlights: clonal evolution and leukemic stem cells in aml
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
9:38
pathology-acute myeloid leukemia | aml made easy | clinical features and diagnosis #acuteleukemias
-
4:13
what important breakthroughs are needed in aml treatment?
-
14:43
current research into post-allosct maintenance therapy in aml
-
1:19
new treatments for aml
-
2:38
session highlights: transforming aml treatment and building on new approaches
-
1:23
mechanical forces in the cll microenvironment and the importance of modeling them in vitro
-
2:43
diagnostic tools for aml
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
4:26
changing treatment landscape of aml
-
3:10
novel aml treament approaches
-
1:33
the importance of measurable residual flt3-itd before allosct for aml
-
8:21
quazar aml-001: a new standard for aml maintenance therapy
-
2:11
beat aml master trial: novel precision medicine approach in aml
-
1:04
clad-ldac-ven induction therapy in aml: insights from a phase ii trial
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
4:36
aml haplo-hsct outcomes